NURS 6630N Midterm Exam (3 Versions)-NURS 6630 - Psychopharmacologic Approaches to Treatment of Psychopathology

, NURS 6630 Midterm Exam
NURS 6630N Midterm EXAM NURS-6630N
Midterm EXAM


 Latest 3 New Versions
 Verified Q & A in Each Version, Verified and 100 % Correct|
 Best document for Exam
 Absolute Satisfaction

, NURS 6630 Midterm Exam
Question1 1 out of
1 points
When an unstable patient asks why it is necessary to add
medications to his current regimen, the PMHNP’s best response
would be:

Selecte C.
d “Many psychiatric illnesses involve several dys-functioning neurotransmitter systems
Answer: in the brain. Often, a single medication may only effect one or two of the dys-
functioning systems. The addition of another medication can work with the current
medication in stabilizing multiple neurotransmitter systems and help to alleviate your
symptoms.”
 Question 2
0 out of 1 points
The PMHNP is meeting with a new mother who would like to
begin taking medication again to treat her bipolar depression;
she is breastfeeding her 2-month old daughter. The PMHNP
recognizes that which of the following medications is
contraindicated for this patient?

Selected C.
Answer: Lithium
(Lithobid)
 Question 3
1 out of 1 points
Mr. Gordon is a middle-aged client who was started on antidepressant
monotherapy for depression. After beginning this medication, the
PMHNP noticed that this client seemed to swing into a hypomanic
episode. What can the PMHNP infer from this behavior change?
Selected A.
Answer: This client may have Bipolar III disorder
 Question 4
1 out of 1 points
A patient presents with frequent episodes of mania. Which
statement describes an appropriate treatment approach for this
patient?

Selected B.
Answer: “The patient could benefit from an
anticonvulsant.”

,  Question 5
1 out of 1 points
The student inquires about antipsychotic medications. Which
response by the PMHNP describes the factors that contribute to
reduced risk of extrapyramidal symptoms (EPS) for patients who
take antipsychotics?

Selected B.
Answer: Those that are potent D2 antagonists with 5HT2A
antagonism properties
 Question 6
1 out of 1 points
After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to monitor for which
possible effect?
Selected D.
Answer: All of the
above
 Question 7
1 out of 1 points
The PMHNP is caring for a patient who is taking antipsychotics
heard the psychiatrist tell the patient that the patient would be
placed on a different antipsychotic agent called an atypical
antipsychotic. What neurotransmitters will this new medication work on?
Selected A.
Answer: dopamine and serotonin
 Question 8
1 out of 1 points
While genes have potential to modify behavior, behavior can
also modify genes. How do genes impact this process?

Selected B.
Answer: Changes made to proteins lead to changes
in behavior.
 Question 9
1 out of 1 points
Mrs. Schwartzman is a 52-year-old client with schizophrenia and no
established history of depression. When meeting with the PMHNP, she
presents with apathy and withdrawn social behavior, and she reports a
loss of joy from enjoyable activities since starting her new medication.
What does the PMHNP infer from this encounter with the client?
Selected C.
Answer: The new medication is blocking D2 receptors in the mesolimbic system
 Question 10
1 out of 1 points